- AT(1) receptor antisense therapy transiently lowers blood pressure in Ren-2 transgenic rats2007 | Second Faculty of Medicine
- Structural compatibility of novel nucleotide modifications with shortened linkages designed for antigene/antisense therapy2004 | Faculty of Mathematics and Physics, Central Library of Charles University
- Antisense Therapy for a Common Corneal Dystrophy Ameliorates TCF4 Repeat Expansion-Mediated Toxicity2018 | First Faculty of Medicine
- New technology in the hypolipidemic drugs development. Inclisiran (LEQVIO)2022 | Faculty of Medicine in Pilsen
- News in the treatment of dyslipidaemia2019 | First Faculty of Medicine
- Current and future trends in the treatment of dyslipidemias2019 | First Faculty of Medicine
- Splice-shifting oligonucleotide (SSO) mediated blocking of an exonic splicing enhancer (ESE) created by the prevalent c.903+469T>C MTRR mutation corrects splicing and restores enzyme activity in patient cells2015 | First Faculty of Medicine
- What will the lipid-lowering therapy in 2014?2014 | First Faculty of Medicine
- Possibilities of influencing lipoprotein (a) concentration2020 | First Faculty of Medicine
- The use of peptide nucleic acids for in situ identification of human chromosomes2005 | Second Faculty of Medicine
- The peptide nucleic acids (PNAs): (high-tech) probes for genetic and molecular cytogenetic investigations2005 | Second Faculty of Medicine